Effect of phosphodiesterase type 5 inhibition on microvascular coronary dysfunction in women: A women's ischemia syndrome evaluation (wise) ancillary study

Clinical Cardiology

Volumn 34, Issue 8, 2011, Pages 483-487

  Denardo, Scott J ^a   Wen, Xuerong ^b   Handberg, Eileen M ^b   Bairey Merz, C Noel ^c   Sopko, George S ^d   Cooper Dehoff, Rhonda M ^e   Pepine, Carl J ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PHOSPHODIESTERASE V; SILDENAFIL;

ADULT; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY BLOOD FLOW; DOPPLER FLOWMETER; DRUG EFFECT; DRUG RESPONSE; ENZYME INHIBITION; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MICROVASCULAR ISCHEMIA; SYMPTOM;

ADENOSINE; ADULT; AGED; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; CORONARY VESSELS; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; LINEAR MODELS; MICROCIRCULATION; MICROVESSELS; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PHOSPHODIESTERASE 5 INHIBITORS; PIPERAZINES; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PURINES; SULFONES; TREATMENT OUTCOME; UNITED STATES; VASODILATOR AGENTS; WOMEN'S HEALTH;

EID: 80051545460     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20935     Document Type: Article

References (29)

1. Cannon RO III,. Microvascular angina and the continuing dilemma of chest pain with normal coronary angiograms. J Am Coll Cardiol. 2009; 54: 877-885.
2. Pepine CJ, Anderson RD, Sharaf BL, et al. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia: results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study. J Am Coll Cardiol. 2010; 55: 2825-2832.
3. Chilian WM, Kuo L, DeFily DV, et al. Endothelial regulation of coronary microvascular tone under physiological and pathophysiological conditions. Eur Heart J. 1993; 14 (suppl I): 55-59. (Pubitemid 23362594)
4. Lapu-Bula R, Ofili E., From hypertension to heart failure: role of nitric oxide-mediated endothelial dysfunction and emerging insights from myocardial contrast echocardiography. Am J Cardiol. 2007; 99 (6B): 7D-14D.
5. Merz CN, Kelsey SF, Pepine CJ, et al. The Women's Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report. J Am Coll Cardiol. 1999; 33: 1453-1461.
6. Shaw LJ, Bairey Merz CN, Pepine CJ, et al. WISE Investigators. Insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol. 2006; 47 (3 suppl): S4-S20.
7. Bairey Merz CN, Shaw LJ, Reis SE, et al. WISE Investigators. Insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol. 2006; 47 (3 suppl): S21-S29.
8. Reis SE, Holubkov R, Conrad Smith AJ, et al. WISE Investigators. Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study. Am Heart J. 2001; 141: 735-741. (Pubitemid 32378481)
9. Sharaf BL, Pepine CJ, Kerensky RA, et al. WISE Study Group. Detailed angiographic analysis of women with suspected ischemic chest pain (pilot phase data from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation [WISE] Study Angiographic Core Laboratory). Am J Cardiol. 2001; 87: 937-941. (Pubitemid 32299974)
10. Kaski JC., Overview of gender aspects of cardiac syndrome X. Cardiovasc Res. 2002; 53: 620-626. (Pubitemid 34175254)
11. Hayward CS, Kelly RP, Collins P., The roles of gender, the menopause and hormone replacement on cardiovascular function. Cardiovasc Res. 2000; 46: 28-49. (Pubitemid 30155943)
12. Gillies HC, Roblin D, Jackson G., Coronary and systemic hemodynamic effects of sildenafil citrate: from basic science to clinical studies in patients with cardiovascular disease. Int J Cardiol. 2002; 86: 131-141. (Pubitemid 35284801)
13. Jackson G., Phosphodiesterase type-5 inhibitors in cardiovascular disease: experimental models and potential clinical applications. Eur Heart J. 2002; 4: H19-H23. (Pubitemid 35396800)
14. Fox KM, Thadani U, Ma PT, et al. CAESAR I (Clinical American and European Studies of Angina and Revascularization) Investigators. Sildenafil citrate does not reduce exercise tolerance in men with erectile dysfunction and chronic stable angina. Eur Heart J. 2003; 24: 2206-2212. (Pubitemid 37522673)
15. Traverse JH, Chen YJ, Du R, et al. Cyclic nucleotide phosphodiesterase type 5 activity limits blood flow to hypoperfused myocardium during exercise. Circulation. 2000; 102: 2997-3002.
16. Halcox JP, Nour KR, Zalos G, et al. The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia. J Am Coll Cardiol. 2002; 40: 1232-1240.
17. Herrmann HC, Chang G, Klugherz BD, et al. Hemodynamic effects of sildenafil in men with severe coronary artery disease. N Engl J Med. 2000; 342: 1622-1626. (Pubitemid 30341530)
18. Dietz U, Tries HP, Merkle W, et al. Coronary artery flow reserve in diabetics with erectile dysfunction using sildenafil. Cardiovasc Diabetol. 2003; 2: 8.
19. Day LJ, Sowton E., Clinical features and follow-up of patients with angina and normal coronary arteries. Lancet. 1976; 2: 334-337.
20. Ockene IS, Shay MJ, Alpert JS, et al. Unexplained chest pain in patients with normal coronary arteriograms: a follow-up study of functional status. N Engl J Med. 1980; 303: 1249-1252. (Pubitemid 11194147)
21. Isner JM, Salem DN, Banas JS Jr, et al. Long-term clinical course of patients with normal coronary arteriography: follow-up study of 121 patients with normal or nearly normal coronary arteriograms. Am Heart J. 1981; 102: 645-653. (Pubitemid 11030023)
22. Halcox JP, Schenke WH, Zalos G, et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation. 2002; 106: 653-658. (Pubitemid 34851922)
23. Britten MB, Zeiher AM, Schächinger V., Microvascular dysfunction in angiographically normal or mildly diseased coronary arteries predicts adverse cardiovascular long-term outcome. Coron Artery Dis. 2004; 15: 259-264. (Pubitemid 39061609)
24. Johnson BD, Shaw LJ, Buchthal SD, et al. National Institutes of Health-National Heart, Lung, and Blood Institute. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation. 2004; 109: 2993-2999. (Pubitemid 38808322)
25. Shaw LJ, Merz CN, Pepine CJ, et al. WISE Investigators. The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. Circulation. 2006; 114: 894-904. (Pubitemid 44337132)
26. Bella AJ, Deyoung LX, Al-Numi M, et al. Daily administration of phosphodiesterase type 5 inhibitors for urological and nonurological indications. Eur Urol. 2007; 52: 990-1005. (Pubitemid 47334787)
27. Schmid I, Didier D, Pfammatter T, et al. Effects of non-ionic iodinated contrast media on patient heart rate and pressures during intra-cardiac or intra-arterial injection. Int J Cardiol. 2007; 118: 389-396. (Pubitemid 46678255)
28. De Bruyne B, Bartunek J, Sys SU, et al. Simultaneous coronary pressure and flow velocity measurements in humans: feasibility, reproducibility, and hemodynamic dependence of coronary flow velocity reserve, hyperemic flow versus pressure slope index, and fractional flow reserve. Circulation. 1996; 94: 1842-1849. (Pubitemid 26349295)
29. Mancini GB, Henry GC, Macaya C, et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease: the TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation. 1996; 94: 258-265. (Pubitemid 26266107)